# Alpha-Adrenoceptor Blockers: Vet Drug Guide An alpha-adrenoceptor blocker is a drug that occupies alpha adrenergic receptors and prevents norepinephrine and other catecholamines from activating them. In [veterinary medicine](/blog/careers/veterinary-medicine-careers-from-clinical-practice-to-public-health) these drugs are used mainly to relax smooth muscle in the lower urinary tract and to control blood pressure driven by catecholamine excess. The two drugs veterinarians reach for most often are phenoxybenzamine, a nonselective alpha-1 and alpha-2 antagonist used for urethral sphincter mechanism incompetence in dogs and for preoperative preparation of pheochromocytoma, and prazosin, a selective alpha-1 antagonist used to relieve functional urethral obstruction in dogs and cats. Alpha-2 agonists such as dexmedetomidine and xylazine sit on the opposite side of the same receptor family and are included here as a contrast class because they produce sedation and vasoconstriction rather than blockade. This article is educational and is not a substitute for veterinary diagnosis or treatment. ## At a Glance | Drug | Receptor subtype | Species and label status | Route | Onset | Duration | Prescription status | |--|--|--|--|--|--|--| | Phenoxybenzamine | Nonselective alpha-1 and alpha-2 antagonist | Dogs (urethral sphincter mechanism incompetence and pheochromocytoma preparation). Cats studied experimentally | Oral | Days for full urethral effect | Roughly 20 hours after a single dose | Prescription | | Prazosin | Selective alpha-1 antagonist | Dogs and cats, extralabel | Oral, or intravenous in hospital settings | Within 10 to 20 minutes after IV dosing in dogs | Several hours | Prescription | | Acepromazine | Nonselective alpha-1 antagonist (also dopaminergic) | Dogs and cats, extralabel for urethral relaxation | Oral, intramuscular, intravenous | Minutes to hours depending on route | Several hours | Prescription | | Phentolamine | Nonselective alpha-1 and alpha-2 antagonist | Dogs, experimental and hospital use | Intravenous | Minutes | Short | Prescription, hospital use | | Dexmedetomidine | Alpha-2 agonist | Dogs and cats, labeled for sedation and analgesia | Intravenous, intramuscular | Minutes | Dose dependent | Prescription | | Xylazine | Alpha-2 agonist | Dogs, cats, horses, labeled for sedation | Intravenous, intramuscular | Minutes | Dose dependent | Prescription | Doses are not listed here because most veterinary use of alpha antagonists is extralabel and no single label dose covers every indication. Your veterinarian will set the dose from the patient's weight, diagnosis, and response. ## What Alpha-Adrenoceptor Blockers Are and What They Treat Alpha adrenergic receptors are [G protein coupled receptors](/blog/guides/g-protein-coupled-receptors) that respond to norepinephrine and epinephrine. They divide into alpha-1 and alpha-2 families. Alpha-1 receptors sit on the smooth muscle of blood vessels, the prostate, the urethra, the vas deferens, and the iris dilator muscle. When norepinephrine binds an alpha-1 receptor, intracellular calcium rises and the muscle contracts. Alpha-2 receptors sit on presynaptic nerve terminals and on some vascular smooth muscle. Presynaptic alpha-2 activation reduces norepinephrine release, which is why alpha-2 agonists lower sympathetic outflow in some tissues while constricting vessels in others. An alpha-adrenoceptor blocker, also called an alpha adrenergic antagonist, occupies these receptors without activating them. The clinical result depends entirely on which subtype is blocked and where that subtype is expressed. Blocking alpha-1 receptors in the urethra lowers urethral closure pressure and makes it easier for the bladder to empty. Blocking alpha-1 receptors in blood vessels causes vasodilation and lowers blood pressure. Blocking alpha-2 receptors removes the brake on norepinephrine release, which can increase sympathetic tone and heart rate. The three practical categories are: 1. Nonselective alpha antagonists (phenoxybenzamine, phentolamine). These block alpha-1 and alpha-2 receptors. Phenoxybenzamine binds covalently and irreversibly, so its effect lasts until new receptors are synthesized, which takes roughly a day or more. 2. Selective alpha-1 antagonists (prazosin, tamsulosin, silodosin, terazosin, alfuzosin, naftopidil). These block alpha-1 receptors and spare alpha-2 receptors. Within the alpha-1 family, some drugs are further selective for the alpha-1A subtype that dominates the prostate and urethra, which reduces blood pressure side effects. 3. Alpha-2 agonists (dexmedetomidine, xylazine, clonidine). These activate rather than block alpha-2 receptors. They are not alpha blockers, but they act on the same receptor family and are the pharmacological mirror image. ## How Alpha-Adrenoceptor Blockers Work ### Receptor subtype selectivity Subtype selectivity is the single most important pharmacological fact about this drug class. The alpha-1A subtype predominates in the prostate and urethra of dogs, and it is the receptor that mediates norepinephrine induced smooth muscle contraction in those tissues [1]. The alpha-1B and alpha-1D subtypes dominate vascular smooth muscle. A drug that blocks all alpha-1 subtypes equally will relax the urethra and drop blood pressure at the same dose. A drug that preferentially blocks alpha-1A will relax the urethra at doses that leave blood pressure largely alone. This property is called uroselectivity. The canine studies make the point cleanly. In anesthetized male dogs, tamsulosin, prazosin, and bunazosin all reduced prostatic pressure in the urethral pressure profile in a dose dependent way, but at the highest dose tamsulosin had less hypotensive effect than prazosin and bunazosin [2]. In a decerebrate dog model, the alpha-1A selective antagonist KMD-3213 (silodosin) was 12 fold more uroselective than prazosin and 7.5 fold more uroselective than tamsulosin [3]. A later study using isolated canine prostate and carotid artery reported prostatic selectivity values of 79.4 for silodosin, 1.78 for tamsulosin, 0.55 for naftopidil, and 0.01 for prazosin [4]. In anesthetized female dogs, tamsulosin lowered maximal urethral pressure with almost no effect on mean arterial blood pressure, while prazosin and urapidil lowered urethral pressure and blood pressure together [5]. ### Why subtype selectivity matters clinically Selectivity determines which side effects appear and at what dose. A nonselective alpha antagonist such as phenoxybenzamine will relax the urethra but will also cause hypotension, reflex tachycardia, and miosis because it blocks alpha-1 receptors in vessels and the iris. An alpha-1A selective drug can achieve the same urethral relaxation with far less hypotension. When a patient cannot tolerate a blood pressure drop, an alpha-1A selective agent is the logical choice. When the goal is deliberate, deep blockade of catecholamine effects, as in pheochromocytoma preparation, a nonselective irreversible antagonist is preferred because it cannot be displaced by a surge of catecholamines. ### The alpha-2 contrast class Alpha-2 agonists activate the receptor rather than block it. Intrathecal clonidine in decerebrate dogs significantly decreased minimum, maximum, and mean intraurethral pressure during the collecting phase and reduced external urethral sphincter activity, while the alpha-2 antagonist yohimbine increased bladder volume and urethral pressure [6][7]. This confirms that alpha-2 activity modulates urethral closure through presynaptic receptors, and it explains why alpha-2 agonists cause sedation, bradycardia, and initial vasoconstriction rather than the vasodilation seen with alpha-1 blockade. The two classes should never be confused at the pharmacy shelf. ## Clinical Uses in Urology ### Phenoxybenzamine for urethral sphincter mechanism incompetence in dogs Urethral sphincter mechanism incompetence is the most common cause of urinary incontinence in spayed female dogs. The urethra is held closed partly by alpha-1 mediated smooth muscle tone. Blocking that tone lowers urethral closure pressure and improves continence. Phenoxybenzamine is the classic drug for this indication because its irreversible, nonselective blockade produces a smooth and sustained reduction in urethral tone. The canine evidence supports the urethral effect. In non-sedated male Beagle dogs, phenoxybenzamine at 0.2 mg/kg intravenously produced less consistent reductions in maximal urethral pressure and urethral closure pressure than prazosin, but the reductions were measurable [8]. In anesthetized male cats, phenoxybenzamine significantly decreased intraurethral pressure by 14 percent in the preprostatic region of the urethra only [9]. The species difference in the cat study is a reminder that urethral pharmacology is not identical across species. ### Prazosin for urethral obstruction Prazosin is a selective alpha-1 antagonist that is readily available and useful in the management of functional urethral obstruction in companion animals [8]. Functional obstruction means the urethra is narrowed by smooth muscle spasm or increased tone rather than by a physical blockage such as a stone or stricture. Prazosin relaxes that smooth muscle and can restore flow. In non-sedated male Beagle dogs, intravenous prazosin at 0.025 mg/kg significantly reduced maximal urethral pressure, maximal urethral closure pressure, and the post peak nadir at nearly all measurement intervals compared with placebo, with maximal urethral effects at 20 minutes and maximal blood pressure effects by 10 minutes [8]. Prazosin produced more consistently significant urethral changes than phenoxybenzamine in the same model [8]. Prazosin is also used in cats with urethral obstruction, though this is extralabel and the evidence base is thinner. The mechanism is the same: alpha-1 blockade reduces smooth muscle tone in the urethra. ### Acepromazine as an adjunct Acepromazine is a phenothiazine tranquilizer with alpha-1 antagonist properties. In anesthetized male cats, acepromazine significantly decreased intraurethral pressures in the preprostatic region by 19 percent and the prostatic region by 21 percent, with no effect on the postprostatic or penile segment [9]. It did not inhibit binding to nicotinic receptors in skeletal muscle, confirming that its urethral effect is smooth muscle mediated rather than striated muscle mediated [9]. Acepromazine is sometimes used for short term urethral relaxation, but its sedative and hypotensive effects limit repeated use. ### Other alpha-1 antagonists studied in dogs Tamsulosin, silodosin, naftopidil, alfuzosin, terazosin, and urapidil have all been studied in canine models of urethral and prostatic pressure. Tamsulosin dose-dependently inhibited hypogastric nerve stimulation induced intraurethral pressure elevation with ED50 values of 0.72 and 0.74 micrograms per kilogram intravenously in male and female dogs respectively, with only slight decreases in mean arterial blood pressure [10]. Silodosin showed the highest prostatic selectivity of the group [4]. These drugs are not commonly used in general veterinary practice, but they illustrate the principle that uroselectivity can be engineered. ## Clinical Uses in Anesthesia and Critical Care ### Pheochromocytoma preparation Pheochromocytoma is a functional tumor of the adrenal medullary chromaffin cells that releases excessive catecholamines [11]. The excess catecholamine causes chronic vasoconstriction and systemic hypertension. Preoperative treatment with an alpha-1 antagonist such as phenoxybenzamine reverses that chronic vasoconstriction before surgery, which reduces the risk of a hypertensive crisis during tumor manipulation [11]. In a 12 year old dog with a metanephrine secreting adrenocortical carcinoma and persistent systemic hypertension of 160 to 210 mmHg, preoperative phenoxybenzamine therapy was followed by laparoscopic adrenalectomy, and urinary catecholamine metabolite concentrations normalized after surgery [12]. A multi-institutional study of 302 dogs undergoing unilateral adrenalectomy found that preoperative medical treatment other than phenoxybenzamine was significantly associated with increased perioperative mortality, which supports phenoxybenzamine as the preferred preoperative agent for catecholamine secreting tumors [13]. ### Managing hypotension during adrenalectomy Alpha blockade is not without intraoperative consequences. In a dog treated with phenoxybenzamine for one month before adrenalectomy, arterial hypotension was present for 195 minutes during surgery and required fluid boluses, dopamine at 5 to 15 micrograms per kilogram per minute, and phenylephrine at 0.1 to 0.5 micrograms per kilogram per minute [11]. This case shows the trade-off: preoperative alpha blockade protects against hypertensive crisis but leaves the patient dependent on vasopressor support once the tumor's catecholamine source is removed. ### Tick paralysis Phenoxybenzamine has been studied as an adjunct in the treatment of advanced tick paralysis caused by Ixodes holocyclus. In a controlled study, all control dogs died rapidly, one dog survived and three died after hyperimmune serum alone, and all four dogs recovered rapidly when phenoxybenzamine hydrochloride was given with hyperimmune serum [14]. The rationale was to attenuate the arterial hypertension associated with the disease [14]. This is a narrow, historical indication and not a routine use. ## What Alpha-Adrenoceptor Blockers Do Not Cover Alpha blockers do not dissolve urinary stones, do not relieve obstruction caused by a stricture, tumor, or foreign body, and do not treat urinary tract infection. They do not restore urethral tone in patients with a denervated or fibrotic sphincter. They do not lower blood pressure in animals whose hypertension is driven by volume overload, renal disease, or hyperaldosteronism rather than catecholamines. They do not reverse the metabolic effects of pheochromocytoma, only the hemodynamic ones. They do not treat pain, and they do not replace fluid therapy or antibiotic therapy when those are indicated. ## How Alpha-Adrenoceptor Blockers Are Given Phenoxybenzamine is given orally. It is available as capsules and is compounded for veterinary use. The full urethral effect develops over several days because the drug works by irreversible receptor alkylation and the body must synthesize new receptors. A single dose lasts roughly 20 hours, so most regimens use once or twice daily dosing. Prazosin is given orally for outpatient use and intravenously in hospital settings. Oral bioavailability is reasonable but not complete, and the first dose can cause a sharp drop in blood pressure. Giving the first dose at home in the evening, when the pet is calm and the owner can observe, reduces the risk of first dose syncope. In the canine study, intravenous prazosin at 0.025 mg/kg produced measurable urethral and blood pressure effects within 10 to 20 minutes [8]. Acepromazine is given orally, intramuscularly, or intravenously. Its urethral effect is shorter than phenoxybenzamine's and its sedative effect is pronounced. Alpha-2 agonists such as dexmedetomidine and xylazine are given intravenously or intramuscularly in hospital settings. They are not interchangeable with alpha blockers. ## Side Effects and What to Do About Them ### Hypotension Hypotension is the most predictable adverse effect of alpha-1 blockade. In non-sedated dogs, prazosin at 0.025 mg/kg intravenously significantly reduced systolic, diastolic, and mean arterial blood pressures at nearly all treatment intervals compared with placebo, with maximal decreases by 10 minutes [8]. Phenoxybenzamine produced less consistent blood pressure reductions in the same model [8]. In the pheochromocytoma case, hypotension during surgery required vasopressor support [11]. What to do: Monitor blood pressure during initiation and dose changes. If systolic pressure falls below the lower end of the reference range for the species, reduce the dose or stop the drug and contact the veterinarian. Do not give a second dose to a pet that is weak, collapsing, or has pale mucous membranes. ### Reflex tachycardia When blood pressure drops, the baroreceptor reflex increases heart rate. This is a compensatory response, not a primary cardiac effect. A study of a novel alpha-1 blocker noted that it decreased mean arterial blood pressure in rats and guinea pigs without eliciting the tachycardia commonly observed with other alpha-1 blockers [15]. In dogs, phenoxybenzamine and prazosin both reduced blood pressure, and the reflex tachycardia that follows is expected [8]. What to do: A mild increase in heart rate is tolerable. A sustained rate above the upper reference range, or a rate accompanied by arrhythmia, warrants veterinary reassessment. ### Miosis Alpha-1 receptors in the iris dilator muscle mediate dilation. Blocking them causes miosis, a constricted pupil. This is most noticeable with nonselective agents such as phenoxybenzamine. Miosis alone is not dangerous, but it can reduce vision in dim light and can be mistaken for other ocular disease. What to do: No treatment is needed. Tell the veterinarian if the pet seems visually impaired. ### Sedation Sedation is a prominent effect of alpha-2 agonists and a lesser effect of phenoxybenzamine and acepromazine. Dexmedetomidine and xylazine produce dose dependent sedation and analgesia, which is their intended clinical effect. Phenoxybenzamine can cause lethargy, especially at higher doses. What to do: Reduce activity and monitor mentation. Persistent profound sedation should prompt a dose review. ### First dose syncope First dose syncope is a sudden loss of consciousness caused by a sharp drop in blood pressure after the first dose of an alpha-1 antagonist. It is more likely with prazosin than with phenoxybenzamine because prazosin has a more abrupt onset. The canine study showed that prazosin's maximal blood pressure effect occurred by 10 minutes after intravenous administration [8]. What to do: Give the first dose when the pet can be observed and when it is not going to be asked to exercise. If syncope occurs, keep the pet recumbent, contact the veterinarian, and do not repeat the dose until the veterinarian has reassessed. ### Other effects Phenoxybenzamine can cause gastrointestinal upset, including nausea and diarrhea. Alpha-1 antagonists as a class can cause nasal stuffiness in humans, and a similar effect is possible in animals, though it is rarely reported. Alpha-1 antagonists can also inhibit contraction of the vas deferens, which is relevant to fertility in breeding males [16]. ## Which Animals Should Not Receive Alpha-Adrenoceptor Blockers Alpha blockers should be avoided or used with extreme caution in animals with: 1. Known hypersensitivity to the specific drug. 2. Pre-existing hypotension or hypovolemia. Blocking alpha-1 receptors in a patient who is already vasodilated can cause collapse. 3. Severe cardiac disease with limited ability to compensate for vasodilation. 4. Concurrent use of other vasodilators, general anesthetics, or phosphodiesterase-5 inhibitors, all of which compound hypotension. 5. Pregnancy and breeding status. The effect on the vas deferens and on uterine tone is not fully characterized in dogs and cats, and breeding males may have reduced fertility [16]. 6. Hepatic impairment. Phenoxybenzamine and prazosin are metabolized in the liver, and dose reduction may be needed. ## Drug Interactions Alpha blockers interact with several drug classes: 1. Other antihypertensives and vasodilators. Additive hypotension. 2. General anesthetics. Additive hypotension and blunting of compensatory tachycardia. 3. Phosphodiesterase-5 inhibitors. Additive vasodilation and hypotension. 4. Alpha-2 agonists. Pharmacological antagonism. An alpha-2 agonist such as dexmedetomidine constricts vessels while an alpha-1 blocker dilates them, so the combination produces unpredictable hemodynamics. 5. Beta-2 agonists and other sympathomimetics. Reduced efficacy of the alpha component of the response. 6. Catecholamines and vasopressors. Phenoxybenzamine's irreversible blockade can make phenylephrine and norepinephrine less effective during surgery, which is why higher infusion rates may be needed [11]. ## How Alpha-Adrenoceptor Blockers Compare With Alternatives For urethral sphincter mechanism incompetence in dogs, the main alternatives are phenylpropanolamine, a sympathomimetic that increases urethral tone, and estrogen supplementation in spayed females. Phenoxybenzamine relaxes the urethra, while phenylpropanolamine tightens it. They are used for different problems. Phenoxybenzamine is chosen when the sphincter is too tight, phenylpropanolamine when it is too loose. For functional urethral obstruction, the alternatives are alpha-1 selective antagonists such as tamsulosin or silodosin, which produce less hypotension, and direct smooth muscle relaxants such as dantrolene or diazepam, which act on striated rather than smooth muscle. Prazosin remains the most accessible alpha-1 antagonist in general practice. For pheochromocytoma preparation, phenoxybenzamine is the standard because its irreversible, nonselective blockade cannot be overcome by a catecholamine surge. Selective alpha-1 antagonists are less reliable for this purpose because the tumor can release enough catecholamine to displace a reversible antagonist. For sedation and analgesia, alpha-2 agonists are the alternative to alpha blockers, not a substitute. Dexmedetomidine and xylazine activate alpha-2 receptors to produce sedation, muscle relaxation, and analgesia. They are used for procedures, not for urethral relaxation. ## Questions to Ask a Veterinarian 1. Is my pet's problem caused by smooth muscle spasm or by a physical obstruction? 2. Which alpha receptor subtype does this drug target, and what does that mean for my pet's blood pressure? 3. What is the target dose, and is it being used on label or extralabel? 4. How should I monitor my pet's blood pressure and heart rate at home? 5. What should I do if my pet collapses or seems weak after a dose? 6. Are there other drugs my pet is taking that could interact? 7. How long until we expect improvement, and when should we recheck? 8. Is this drug safe for a breeding animal? ## Clinical Relevance, Limitations and Common Mistakes Alpha-adrenoceptor blockers are a small but important part of veterinary pharmacology. Their clinical relevance rests on three facts. First, alpha-1 receptors mediate smooth muscle tone in the urethra and prostate, so blocking them relieves functional obstruction and reduces urethral closure pressure [2][8][10]. Second, subtype selectivity determines whether a drug lowers blood pressure at the same dose that relaxes the urethra, and the canine literature shows a wide range of selectivity across agents [3][4]. Third, nonselective irreversible blockade with phenoxybenzamine is the standard preoperative preparation for catecholamine secreting tumors because it cannot be displaced by a catecholamine surge [11][13]. The limitations are equally clear. Most veterinary use of alpha antagonists is extralabel, which means the dose, duration, and monitoring plan are based on clinical experience and species specific studies rather than a product label. The evidence base is strongest in dogs and thinner in cats. The canine studies cited here used intravenous dosing and urethral pressure profilometry, which are research methods, not routine clinical tools. The translation from a decerebrate dog model to a 12 year old spayed female dog with incontinence is not automatic. Common mistakes include: 1. Confusing alpha blockers with alpha-2 agonists. They have opposite effects at the receptor. 2. Giving the first dose of prazosin without warning the owner about first dose syncope. 3. Expecting phenoxybenzamine to work within hours. It takes days to reach full effect. 4. Using an alpha blocker for a physical obstruction such as a urethral stone. The drug will not dissolve the stone. 5. Failing to monitor blood pressure during initiation and dose changes. 6. Continuing an alpha blocker in a pet that has become hypotensive or lethargic. 7. Assuming that a drug studied in male dogs will behave identically in female dogs. The tamsulosin study in female dogs showed that urethral effects are similar across sexes, but the prostatic contribution is absent in females [5][10]. Individual cases need a veterinarian who can examine the patient, measure blood pressure, and adjust therapy. This article is educational and is not a substitute for veterinary diagnosis or treatment. ## Frequently Asked Questions ### What is an alpha-adrenoceptor blocker? An alpha-adrenoceptor blocker is a drug that occupies alpha adrenergic receptors and prevents norepinephrine from activating them. In veterinary medicine the main uses are relaxing urethral smooth muscle and controlling catecholamine driven hypertension. ### What is the difference between an alpha blocker and an alpha-2 agonist? An alpha blocker occupies the receptor and prevents activation. An alpha-2 agonist activates the receptor. They produce opposite effects at the same receptor family, so they are never interchangeable. ### Why does subtype selectivity matter? Subtype selectivity determines which tissues are affected at a given dose. Alpha-1A selective drugs relax the urethra with less blood pressure reduction than nonselective drugs, which reduces the risk of hypotension and syncope. ### Is phenoxybenzamine the same as prazosin? No. Phenoxybenzamine is a nonselective, irreversible alpha-1 and alpha-2 antagonist. Prazosin is a selective, reversible alpha-1 antagonist. Phenoxybenzamine lasts longer and is preferred for pheochromocytoma preparation. Prazosin is preferred for functional urethral obstruction. ### Can alpha blockers be used in cats? Yes, but most use is extralabel and the evidence base is thinner than in dogs. Phenoxybenzamine and acepromazine have both been shown to reduce intraurethral pressure in anesthetized male cats [9]. ### What is first dose syncope? First dose syncope is a sudden loss of consciousness caused by a sharp drop in blood pressure after the first dose of an alpha-1 antagonist. It is more likely with prazosin than with phenoxybenzamine. ### How long does phenoxybenzamine take to work? Phenoxybenzamine works by irreversible receptor blockade, so the full effect develops over several days as receptors are alkylated. A single dose lasts roughly 20 hours. ### What should I monitor at home? Watch for weakness, collapse, pale gums, lethargy, and a racing heart. These signs suggest hypotension or reflex tachycardia and should prompt a call to the veterinarian. ## Related Articles - [Drug Interactions with Cardiovascular Medications in Veterinary Patients: Beta-Blockers, ACE Inhibitors, and More](/knowledge/veterinary-medicine/clinical-pharmacology/drug-interactions-cardiovascular-veterinary) - [Purification of Alpha-Synuclein](/knowledge/molecular-biology/purification-of-alpha-synuclein-resin-selection-and-chromatographic-strategies) - [Famotidine H2 Blocker Dose: Gastric Acid Reduction Guide Dogs Cats](/knowledge/veterinary-medicine/calculators-clinical-tools/famotidine-h2-blocker-dose-gastric-acid-reduction-guide-dogs-cats) - [Atenolol Cat Heart Dose: Beta Blocker Feline Heart Protocol](/knowledge/veterinary-medicine/calculators-clinical-tools/atenolol-cat-heart-dose-beta-blocker-feline-heart-protocol) - [Alpha and Beta Diversity in Metagenomics: A Practical Guide to Measuring and Comparing Microbial Community Structure](/knowledge/bioinformatics/alpha-and-beta-diversity-in-metagenomics-a-practical-guide-to-measuring-and-comparing-microbial-comm) - [AOD-9604 (hGH 177-191 Fragment): Lipolytic Beta-3 Adrenergic Mechanisms, Chondrogenic Repair, and Reconstitution Mathematics](/knowledge/molecular-biology/aod-9604-lipolytic-hgh-fragment-beta3-adrenergic-mechanisms) - [Agonist vs Antagonist: Drug Receptor Actions Explained](/knowledge/veterinary-medicine/clinical-pharmacology/agonist-vs-antagonist-drug-receptor-actions-explained) - [Anti-Nausea Drugs for Dogs: Vet Guide](/knowledge/veterinary-medicine/pet-medication-guide/anti-nausea-drugs-for-dogs-vet-guide) - [Prokinetic Agents: Drug Classes and GI Uses](/knowledge/veterinary-medicine/clinical-pharmacology/prokinetic-agents-drug-classes-and-gi-uses) ## Sources 1. [Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.](https://pubmed.ncbi.nlm.nih.gov/12749888/) 2. [Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs.](https://pubmed.ncbi.nlm.nih.gov/8884461/) 3. [Effect of KMD-3213, an alpha1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs.](https://pubmed.ncbi.nlm.nih.gov/11260350/) 4. [Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.](https://pubmed.ncbi.nlm.nih.gov/16894620/) 5. [Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs.](https://pubmed.ncbi.nlm.nih.gov/16536901/) 6. [[Roles of sacral spinal alpha-adrenoceptive mechanism in micturition reflex in the decerebrate dog].](https://pubmed.ncbi.nlm.nih.gov/7869649/) 7. [[Alpha adrenergic mechanism on the reflex micturition in the male decerebrate dog].](https://pubmed.ncbi.nlm.nih.gov/7684100/) 8. [Urethral pressure profile and hemodynamic effects of phenoxybenzamine and prazosin in non-sedated male beagle dogs.](https://pubmed.ncbi.nlm.nih.gov/12528826/) 9. [Effects of acepromazine maleate and phenoxybenzamine on urethral pressure profiles of anesthetized, healthy, sexually intact male cats.](https://pubmed.ncbi.nlm.nih.gov/8896691/) 10. [Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia.](https://pubmed.ncbi.nlm.nih.gov/15336951/) 11. [Management of refractory hypotension during adrenalectomy in a dog treated with phenoxybenzamine.](https://pubmed.ncbi.nlm.nih.gov/40189441/) 12. [Metanephrine-secreting adrenocortical carcinoma in a dog with clinical and biochemical features suggestive of pheochromocytoma.](https://pubmed.ncbi.nlm.nih.gov/42284442/) 13. [Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours.](https://pubmed.ncbi.nlm.nih.gov/37652746/) 14. [Infestation in the dog by the paralysis tick, Ixodes holocyclus. 5. Treatment.](https://pubmed.ncbi.nlm.nih.gov/3190588/) 15. [Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors.](https://pubmed.ncbi.nlm.nih.gov/8627571/) 16. [In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.](https://pubmed.ncbi.nlm.nih.gov/18078926/)